Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Started within 48 hours of stroke, neuroprotective medication helped brain cells, recovery
Categories: Stroke News & Brain Health, Scientific Conferences & Meetings
|
Published: February 06, 2026

Started within 48 hours of stroke, neuroprotective medication helped brain cells, recovery

American Stroke Association International Stroke Conference – Late-Breaking Science Abstract LB 032
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Brain illustration

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution.

copyright American Heart Association

Download (426.1 kB)
Brain illustration

Brain illustration

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution.

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (426.1 kB) File Permalink

Shuya Li M.D.

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing

copyright Beijing Tiantan Hospital 

Download (97.2 kB)
Shuya Li M.D.

Shuya Li M.D.

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing

copyright Beijing Tiantan Hospital 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (97.2 kB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Brain illustration
  • Shuya Li M.D.
  • ISC Logo

Related Video

Previous Slide Next Slide

Dr. Li on ISC26 LB 32-LAIS trial overview

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 

Download (174.1 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Li on ISC26 LB 32-LAIS trial overview

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (174.1 MB) File Permalink

Dr. Li on ISC26 LB 32-LAIS trial-improved outcomes

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 

Download (48.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Li on ISC26 LB 32-LAIS trial-improved outcomes

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (48.4 MB) File Permalink

Dr. Li on ISC26 LB 32-LAIS trial-confidence in neuroprotectants

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 

Download (49.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Li on ISC26 LB 32-LAIS trial-confidence in neuroprotectants

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (49.4 MB) File Permalink

Dr. Li on ISC26 LB 32-LAIS trial-time window extended

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 

Download (141.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Li on ISC26 LB 32-LAIS trial-time window extended

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

Transcript (txt)

News release

copyright American Heart Association 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (141.4 MB) File Permalink
  • Dr. Li on ISC26 LB 32-LAIS trial overview
  • Dr. Li on ISC26 LB 32-LAIS trial-improved outcomes
  • Dr. Li on ISC26 LB 32-LAIS trial-confidence in neuroprotectants
  • Dr. Li on ISC26 LB 32-LAIS trial-time window extended
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED